Product Information
VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1916 per EA under NDC 33342007815. Its NADAC has been published 616 times since Jun 18, 2014.
FDA first approved this application on Apr 19, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25; 320 mg/1; mg/1
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342007815
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; VALSARTANApproval Type
Generic (ANDA)
FDA Application
ANDA203145FDA Approved
4/19/2013
TE Code
AB
On Market Since
4/19/2013
Pharmacological Classes
Price Statistics
The NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has been published 616 times since Jun 18, 2014, and over the history we have for it it has declined 47.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1916 per EA |
|---|---|
| All-time high | $0.6097 (Nov 11, 2020) |
| All-time low | $0.1905 (Nov 20, 2024) |
| 52-week high | $0.2220 |
| 52-week low | $0.1916 |
| Median price | $0.2999 |
| Average price | $0.3173 |
| Largest weekly change | +33.7% (Oct 21, 2020) |
| Weeks tracked | 616 |
| Tracking since | Jun 18, 2014 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Valsartan and Hydrochlorothiazide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Angiotensin 2 Receptor Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB, manufactured by Macleods Pharmaceuticals Limited, is $0.1916 per EA (NDC 33342007815), effective Sep 30, 2026.
How has the price of VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB changed over time?
Over the history we have for it, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has declined 47.6%. It has been tracked across 616 weekly CMS publications since Jun 18, 2014.
What are the highest and lowest recorded NADAC prices for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?
Since Jun 18, 2014, the NADAC for VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB has ranged from a low of $0.1905 (Nov 20, 2024) to a high of $0.6097 (Nov 11, 2020), with a median of $0.2999 per EA.
Are there cheaper alternatives to VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB?
VALSARTAN-HYDROCHLOROTHIAZIDE 320-25 MG TAB (NDC 33342007815) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.